SUMITOMO DAINIPPON PHARMA ONCOLOGY
Sumitomo Dainippon Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, DSP Cancer Institute, and Oncology Clinical Development Unit, will collectively be known as Sumitomo Dainippon Pharma Oncology or SDP Oncology.
SUMITOMO DAINIPPON PHARMA ONCOLOGY
Social Links:
Industry:
Health Diagnostics Oncology Pharmaceutical Therapeutics
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.sdponcology.com
Total Employee:
251+
Status:
Active
Contact:
617-674-6800
Technology used in webpage:
Domain Not Resolving SPF Amazon Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS YouTube GoDaddy DNS Amazon Virginia Region Digital Ocean
Similar Organizations
Alliance for Lupus Research
The Alliance for Lupus Research is an American voluntary health organization based in New York City
BAKX Therapeutics
BAKX Therapeutics is a provider of cancer treatment.
Censa Pharmaceuticals
Censa Pharmaceuticals primary focus is the development and commercialization of therapeutics for (ultra) orphan CNS disorders.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
E-Health Now LLC
We are the first HIPAA compliant platform that focuses on optimizing cancer treatment plans for patients in China locally, on a B2B model.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Jing Medicine Technology
Jing Medicine Technology is a developing innovative therapeutics for Oncology, Immunology and CNS disorders.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Sumitomo Pharma Oncology
Sumitomo Pharma Oncology is a developer of novel cancer therapeutics.
Current Employees Featured
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-22 | Sumitomo Dainippon Pharma Oncology Appoints Jatin J. Shah, M.D. as Chief Medical Officer |
Official Site Inspections
http://www.sdponcology.com
- Host name: ec2-3-220-212-11.compute-1.amazonaws.com
- IP address: 3.220.212.11
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Sumitomo Dainippon Pharma Oncology"
Sumitomo Dainippon Pharma Oncology - Crunchbase
Sumitomo Dainippon Pharma Oncology or SDP Oncology. Read More. Lists Featuring This Company. Edit Lists Featuring This Company Section. New England Companies With More Than $10M in Revenue (Top 10K) 9,965 …See details»
Sumitomo Dainippon Pharma Oncology Announces First Patient …
Oct 21, 2021 As a global oncology organization with teams in the U.S. and Japan, SDP Oncology is relentlessly committed to advancing purposeful science by transforming new …See details»
Sumitomo Dainippon Pharma Oncology Announces Its Formation …
Jul 1, 2020 Through scientific persistence and a commitment to discovery, SDP Oncology is focused on advancing a diverse and purposeful pipeline that aims to positively impact …See details»
Sumitomo Dainippon Pharma Oncology Announces Its Formation …
Jul 1, 2020 Augmenting this effort, SDP Oncology's Global Oncology External Innovation Hub enhances collaboration with external organizations, such as academia and venture capital, to …See details»
Sumitomo Dainippon Pharma Oncology Announces First Patient
Apr 8, 2022 Sumitomo Dainippon Pharma Oncology, Inc., is a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. As a global oncology organization with teams in the …See details»
Member Spotlight: Q&A with Sumitomo Dainippon …
Feb 1, 2022 Sumitomo Dainippon Pharma Oncology, Inc. (SDP Oncology) is based in the U.S. and a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. How do your organization’s activities help patients now and into the …See details»
Sumitomo Dainippon Pharma Oncology - VentureRadar
Similar Companies: Sumitomo Pharma Oncology USA n/a Sumitomo Pharma Oncology, Inc. is a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. As a global oncology organization with …See details»
SUMITOMO DAINIPPON PHARMA ONCOLOGY ANNOUNCES ITS …
Jul 1, 2020 Sumitomo Dainippon Pharma Oncology Is Positioned to Advance Meaningful Therapies for Patients with Cancer through Innovative Drug Discovery, Research and …See details»
Sumitomo Dainippon Pharma Oncology Presents New Data from …
Apr 13, 2021 Sumitomo Dainippon Pharma Oncology, Inc., is a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. As a global oncology organization with teams in the …See details»
Sumitomo Dainippon Pharma Oncology Announces Phase 3 …
Feb 9, 2021 As a global oncology organization with teams in the U.S. and Japan, SDP Oncology is relentlessly committed to advancing purposeful science by transforming new discoveries …See details»
Sumitomo Dainippon Pharma Oncology Appoints Jatin J. Shah, …
Feb 22, 2022 As a global oncology organization with teams in the U.S. and Japan, SDP Oncology is relentlessly committed to advancing purposeful science by transforming new …See details»
Sumitomo Dainippon Pharma Oncology Announces Its Formation …
Through scientific persistence and a commitment to discovery, SDP Oncology is focused on advancing a diverse and purposeful pipeline that aims to positively impact outcomes for …See details»
Sumitomo Dainippon Pharma Oncology to Present New Data …
Nov 6, 2020 As a global oncology organization with teams in the U.S. and Japan, SDP Oncology is relentlessly committed to advancing purposeful science by transforming new discoveries …See details»
Sumitomo Dainippon Pharma Oncology Announces Its Formation …
Jul 7, 2020 Through scientific persistence and a commitment to discovery, SDP Oncology is focused on advancing a diverse and purposeful pipeline that aims to positively impact …See details»
Sumitomo Dainippon Pharma Oncology Presents New Data from …
Dainippon Pharma Co., Ltd. As a global oncology organization with teams in the U.S. and Japan, SDP Oncology is relentlessly committed to advancing purposeful science by transforming new …See details»
Sumitomo Dainippon Pharma Oncology Announces First Patient
Recommended Phase 2 dose (RP2D) in recurrent World Health Organization (WHO) Grade III or IV malignant glioma. The trial is being conducted in the United States and Japan. Additional …See details»
Innovative Treatments, Science and Technology | Sumitomo …
Dedicated to improving the health and well-being of people around the world. We drive innovative treatments, science, and technology to address patient needs in the critical areas of psychiatry …See details»